These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16400829)

  • 41. CCR2+Ly-6Chi monocytes are crucial for the effector phase of autoimmunity in the central nervous system.
    Mildner A; Mack M; Schmidt H; Brück W; Djukic M; Zabel MD; Hille A; Priller J; Prinz M
    Brain; 2009 Sep; 132(Pt 9):2487-500. PubMed ID: 19531531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple sclerosis: classification revisited reveals homogeneity and recapitulation.
    Raine CS
    Ann Neurol; 2008 Jan; 63(1):1-3. PubMed ID: 18232014
    [No Abstract]   [Full Text] [Related]  

  • 43. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
    Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
    Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positive and negative implications of tumor necrosis factor neutralization for the pathogenesis of multiple sclerosis.
    Taoufik E; Tseveleki V; Euagelidou M; Emmanouil M; Voulgari-Kokota A; Haralambous S; Probert L
    Neurodegener Dis; 2008; 5(1):32-7. PubMed ID: 18075273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammatory cell migration into the central nervous system: a few new twists on an old tale.
    Man S; Ubogu EE; Ransohoff RM
    Brain Pathol; 2007 Apr; 17(2):243-50. PubMed ID: 17388955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EBV in MS: guilty by association?
    Lünemann JD; Münz C
    Trends Immunol; 2009 Jun; 30(6):243-8. PubMed ID: 19428300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central nervous system: a modified immune surveillance circuit?
    Romo-González T; Chavarría A; Pérez-H J
    Brain Behav Immun; 2012 Aug; 26(6):823-9. PubMed ID: 22310920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Multifactorial pathogenesis and immunoendocrine modulation of multiple sclerosis].
    Akimov GA; Golovkin VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):199-203. PubMed ID: 3577506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current trends in autoimmunity and the nervous system.
    Selmi C; Barin JG; Rose NR
    J Autoimmun; 2016 Dec; 75():20-29. PubMed ID: 27545842
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
    Kleine TO; Benes L
    Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homogeneity of active demyelinating lesions in established multiple sclerosis.
    Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L
    Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Missing links in multiple sclerosis etiology. A working connecting hypothesis.
    Soulillou JP
    Med Hypotheses; 2013 May; 80(5):509-16. PubMed ID: 23466062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Role of Astrocytes in Multiple Sclerosis.
    Ponath G; Park C; Pitt D
    Front Immunol; 2018; 9():217. PubMed ID: 29515568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune tolerance and control of CNS autoimmunity: from animal models to MS patients.
    Cassan C; Liblau RS
    J Neurochem; 2007 Feb; 100(4):883-92. PubMed ID: 17181557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trafficking of lymphocytes into the CNS.
    Schwab N; Schneider-Hohendorf T; Wiendl H
    Oncotarget; 2015 Jul; 6(20):17863-4. PubMed ID: 26255669
    [No Abstract]   [Full Text] [Related]  

  • 57. Role of the blood-brain barrier in multiple sclerosis.
    Ortiz GG; Pacheco-Moisés FP; Macías-Islas MÁ; Flores-Alvarado LJ; Mireles-Ramírez MA; González-Renovato ED; Hernández-Navarro VE; Sánchez-López AL; Alatorre-Jiménez MA
    Arch Med Res; 2014 Nov; 45(8):687-97. PubMed ID: 25431839
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spatial diversity of blood-brain barrier alteration and macrophage invasion in experimental autoimmune encephalomyelitis: a comparative MRI study.
    Ladewig G; Jestaedt L; Misselwitz B; Solymosi L; Toyka K; Bendszus M; Stoll G
    Exp Neurol; 2009 Nov; 220(1):207-11. PubMed ID: 19733560
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
    Coisne C; Mao W; Engelhardt B
    J Immunol; 2009 May; 182(10):5909-13. PubMed ID: 19414741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spinal cord injury triggers systemic autoimmunity: evidence for chronic B lymphocyte activation and lupus-like autoantibody synthesis.
    Ankeny DP; Lucin KM; Sanders VM; McGaughy VM; Popovich PG
    J Neurochem; 2006 Nov; 99(4):1073-87. PubMed ID: 17081140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.